Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1967 1
1968 1
1972 1
1975 1
1976 1
1977 4
1978 3
1979 2
1980 4
1981 3
1982 1
1983 2
1984 9
1985 11
1986 11
1987 10
1988 19
1989 17
1990 21
1991 20
1992 16
1993 23
1994 25
1995 25
1996 19
1997 31
1998 47
1999 43
2000 44
2001 69
2002 65
2003 54
2004 62
2005 85
2006 88
2007 84
2008 74
2009 67
2010 59
2011 65
2012 64
2013 66
2014 64
2015 68
2016 59
2017 57
2018 54
2019 52
2020 55
2021 62
2022 58
2023 62
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

1,764 results

Results by year

Filters applied: . Clear all
Page 1
Factorial design-assisted spectroscopic determination of oxybutynin hydrochloride.
Yosrey E, Elmansi H, Sheribah ZA, El-Sayed Metwally M. Yosrey E, et al. R Soc Open Sci. 2021 Nov 24;8(11):211027. doi: 10.1098/rsos.211027. eCollection 2021 Nov. R Soc Open Sci. 2021. PMID: 34849244 Free PMC article.
In this study, we have developed two facile spectroscopic methods for quantifying oxybutynin (OBT) hydrochloride in its pure form and tablets using design of experiments (DOEs). ...
In this study, we have developed two facile spectroscopic methods for quantifying oxybutynin (OBT) hydrochloride in its pure form and …
A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.
Fujimoto T, Terahara T, Okawa K, Inakura H, Hirayama Y, Yokozeki H. Fujimoto T, et al. J Am Acad Dermatol. 2023 Jul;89(1):62-69. doi: 10.1016/j.jaad.2023.03.025. Epub 2023 Mar 28. J Am Acad Dermatol. 2023. PMID: 36990320 Clinical Trial.
BACKGROUND: No previous controlled studies have been specifically designed or adequately powered to show the efficacy of topical oxybutynin for palmar hyperhidrosis by using quantitative measures. OBJECTIVE: To evaluate efficacy of 20% oxybutynin hydrochloride …
BACKGROUND: No previous controlled studies have been specifically designed or adequately powered to show the efficacy of topical oxybutyn …
Long-term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open-label extension study.
Fujimoto T, Terahara T, Okawa K, Inakura H, Hirayama Y, Yokozeki H. Fujimoto T, et al. J Dermatol. 2023 Nov;50(11):1459-1472. doi: 10.1111/1346-8138.16922. Epub 2023 Aug 21. J Dermatol. 2023. PMID: 37605375 Clinical Trial.
The long-term safety and efficacy of 52-week application of oxybutynin hydrochloride 20% lotion (20% OL) for the treatment of primary palmar hyperhidrosis (PPHH) in Japanese patients aged 12 years were evaluated in an open-label extension (OLE) of a 4-week, randomiz …
The long-term safety and efficacy of 52-week application of oxybutynin hydrochloride 20% lotion (20% OL) for the treatment of …
Transdermal oxybutynin.
Baldwin CM, Keating GM. Baldwin CM, et al. Drugs. 2009;69(3):327-37. doi: 10.2165/00003495-200969030-00008. Drugs. 2009. PMID: 19275276 Review.
*The transdermal oxybutynin system, applied twice weekly, delivers continuous oxybutynin over a 96-hour patch wear period. ...*Transdermal oxybutynin is generally well tolerated in patients with overactive bladder. ...
*The transdermal oxybutynin system, applied twice weekly, delivers continuous oxybutynin over a 96-hour patch wear period. ... …
Adjustment of Conditions for Combining Oxybutynin Transdermal Patch with Heparinoid Cream in Mice by Analyzing Blood Concentrations of Oxybutynin Hydrochloride.
Murakami Y, Sekijima H, Fujisawa Y, Ooi K. Murakami Y, et al. Biol Pharm Bull. 2019 Apr 1;42(4):586-593. doi: 10.1248/bpb.b18-00690. Epub 2019 Jan 25. Biol Pharm Bull. 2019. PMID: 30686806 Free article.
We investigated the effect of heparinoid cream on the transdermal absorption of oxybutynin hydrochloride using an oxybutynin transdermal patch and determined the combined effect of these medications. ...The pharmacokinetics of oxybutynin hydrochlori …
We investigated the effect of heparinoid cream on the transdermal absorption of oxybutynin hydrochloride using an oxybutyni …
Oxybutynin and the overactive bladder.
Andersson KE, Chapple CR. Andersson KE, et al. World J Urol. 2001 Nov;19(5):319-23. doi: 10.1007/pl00007103. World J Urol. 2001. PMID: 11760780 Review.
Oxybutynin is a tertiary amine, which undergoes an extensive first-pass metabolism. It has an active metabolite, N-desethyl oxybutynin, and the effect of oral oxybutynin is to a large extent exerted by this metabolite. ...
Oxybutynin is a tertiary amine, which undergoes an extensive first-pass metabolism. It has an active metabolite, N-desethyl oxybut …
Extended-release oxybutynin.
Comer AM, Goa KL. Comer AM, et al. Drugs Aging. 2000 Feb;16(2):149-55; discussion 156-7. doi: 10.2165/00002512-200016020-00008. Drugs Aging. 2000. PMID: 10755330 Review.
Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride into the gastrointestinal tract over a 24-hour period when taken once daily. ...Mean peak plasma concentrations are lower with extended-rele …
Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride …
Oxybutynin topical and transdermal formulations: an update.
Staskin DR, Salvatore S. Staskin DR, et al. Drugs Today (Barc). 2010 Jun;46(6):417-25. doi: 10.1358/dot.2010.46.6.1487750. Drugs Today (Barc). 2010. PMID: 20571610 Review.
Oxybutynin, an antimuscarinic agent, is well established for the treatment of overactive bladder (OAB) and is the gold standard for the treatment of severe neurogenic bladder. ...Oxybutynin chloride topical gel (OTG) (Gelnique(R), Watson Pharmaceuticals, Corona, CA, …
Oxybutynin, an antimuscarinic agent, is well established for the treatment of overactive bladder (OAB) and is the gold standard for t …
Oxybutynin-induced reflux esophagitis.
Lee M, Sharifi R. Lee M, et al. DICP. 1990 Jun;24(6):583-5. doi: 10.1177/106002809002400604. DICP. 1990. PMID: 2360335
Oxybutynin has less anticholinergic activity than propantheline bromide. ...We report a case of oxybutynin-induced reflux esophagitis. This probably resulted from the anticholinergic action of oxybutynin, which decreased lower esophageal sphincter tone. ...
Oxybutynin has less anticholinergic activity than propantheline bromide. ...We report a case of oxybutynin-induced reflux esop …
Oxybutynin for methadone-induced sweating in pregnancy.
Harley JAT. Harley JAT. Australas Psychiatry. 2021 Aug;29(4):470-471. doi: 10.1177/1039856220965055. Epub 2020 Oct 14. Australas Psychiatry. 2021. PMID: 33052696 No abstract available.
1,764 results